Taubman Institute leaders published in "Academic Medicine" journal

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article, Transforming Science Into Medicine: How Clinician-Scientists Can Build Bridges Across Research's 'Valley of Death," explores the problematic gap between bench research and clinical application of new treatments or cures.  Despite significant increases in National Institutes of Health spending on medical research, this 'valley of death' persists. 

That's due to the declining role of clinician-scientists, the authors state, noting the percentage of M.D.s receiving NIH funding has declined compared with Ph.Ds.  The dearth requires radical action, including greater funding for translational research and more resources for the training, debt relief and early-career support of potential clinician-scientists.

The authors of the article are:

- Dr. Eva Feldman, director, A. Alfred Taubman Medical Research Institute

- Martin A. Fischhoff, managing director, A. Alfred Taubman Medical Research Institute

- Dr. Stacey Sakowski, deputy managing director, A. Alfred Taubman Medical Research Institute

- Scott Roberts, J.D., Dickinson Wright PLLC

Click here to read the entire article.

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists